$1558 #Yichang Hec Changjiang Pha-H YiChang HEC ChangJiang Pharmaceutical - 1Q20: Tepid sales due to COVID-19; OTC sales a bright point: HEC Pharma reported tepid sales of Rmb2b in 1Q20, representing 5.6% yoy growth. The weak sales… https://t.co/BVLBrCAyY1 #equity #stocks